Jeffrey Adam Novack - 24 Apr 2024 Form 3 Insider Report for CareDx, Inc. (CDNA)

Role
Secretary and General Counsel
Signature
/s/ Jeffrey Adam Novack
Issuer symbol
CDNA
Transactions as of
24 Apr 2024
Net transactions value
$0
Form type
3
Filing time
03 May 2024, 16:40:28 UTC
Next filing
03 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDNA Common Stock 126,974 24 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDNA Employee Stock Option (right to buy) 24 Apr 2024 Common Stock 2,385 $18.24 Direct F2
holding CDNA Employee Stock Option (right to buy) 24 Apr 2024 Common Stock 2,150 $37.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Comprised of 7,341 shares of common stock and 119,633 shares of common stock represented by restricted stock units ("RSUs"). The RSUs consist of (1) 5,000 shares granted on November 6, 2021; (2) 7,150 shares granted on April 6, 2022; (3) 1,600 shares granted on August 6, 2022; (4) 11,655 shares granted on November 7, 2022; (5) 7,500 shares granted on April 6, 2023; (6) 10,000 shares granted on June 6, 2023; (7) 10,000 shares granted on July 6, 2023; and (8) 66,728 shares granted on February 1, 2024. Each of the foregoing RSU grants is subject to its own vesting schedule.
F2 The option was originally granted on August 6, 2022. 1/4th of the shares subject to the option vested on August 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.
F3 The option was originally granted on April 6, 2022. 1/4th of the shares subject to the option vested on April 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.